Finance Watch: Resilience Raises $625m, Bringing New Cash To $1.2bn

Series D Round Combined With Prior Unannounced $600m Series C

The biomanufacturing firm National Resilience has raised more than $2bn in venture capital and millions more in fees from government and industry contracts since 2020. Also, Code Biotherapeutics raised $75m in series A cash, Concert grossed $66.4m and Amarin is cutting US jobs. 

Finance Watch Image
• Source: Shutterstock

National Resilience, Inc. has closed a $625m series D venture capital round, bringing its total VC funding during the past 10 months to more than $1.2bn, including a previously unannounced $600m series C round that the biomanufacturing firm closed in August 2021.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Financing

More from Business